Physician profile
Padma Chava
NPI 1508838186
$1,366.64
in general payments reported to CMS, 2019-2025
17 companies · $632 in 2025
The $632 reported for 2025 was more than what 77% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $68.85 · 2021: $67.56 · 2022: $71.88 · 2023: $240 · 2024: $286 · 2025: $632.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,158.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,158.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $484.03 | 2023-2025 | Wegovy, Rybelsus, Ozempic |
| Boehringer Ingelheim Pharmaceuticals, INC. | $154.02 | 2022-2023 | Jardiance, Tradjenta |
| Lilly USA, LLC | $107.93 | 2024-2025 | Zepbound, Mounjaro |
| Merck Sharp & Dohme LLC | $93.99 | 2021-2022 | |
| Astrazeneca Pharmaceuticals Lp | $91.70 | 2023-2025 | Breztri |
| Pfizer INC. | $72.21 | 2022-2025 | |
| Phadia US INC. | $68.85 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $52.18 | 2025 | |
| Abbott Laboratories | $50.73 | 2024-2025 | Cardiomems, Thoratec Heartmate 3 Lvas Implant Kit |
| Abiomed | $42.98 | 2025 | |
| Alnylam Pharmaceuticals INC. | $32.39 | 2024-2025 | Amvuttra, Onpattro |
| Exact Sciences Corporation | $24.46 | 2025 | Cologuard Collection Kit |
| Cardiva Medical, INC. | $24.00 | 2025 | Cardiva Vascade Mvp Vvcs 6-12f |
| Philips North America LLC | $19.87 | 2023 | |
| Cvrx, INC. | $16.66 | 2023 | Barostim Neo System |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $15.64 | 2025 | |
| Paratek Pharmaceuticals, INC. | $15.00 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Padma Chava listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.